Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Covington
Argus Health
Merck
Deloitte
QuintilesIMS

Generated: August 21, 2019

DrugPatentWatch Database Preview

Patent: 8,742,076

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,742,076
Title:Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods
Abstract: The present invention relates to antibody-drug conjugate compounds of Formula I: Ab-(L-D).sub.p I where one or more nemorubicin metabolite or analog drug moieties (D) are covalently attached by a linker (L) to an antibody (Ab) which binds to one or more tumor-associated antigens or cell-surface receptors. These compounds may be useful in methods of diagnosis or treatment of cancer, and other diseases and disorders.
Inventor(s): Cohen; Robert L. (San Mateo, CA), Ha; Edward HyungSuk (San Francisco, CA), Reynolds; Mark E. (Millbrae, CA)
Assignee: Genentech, Inc. (South San Francisco, CA)
Application Number:12/865,354
Patent Claims:see list of patent claims

Details for Patent 8,742,076

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25   Try a Free Trial Genentech, Inc. (South San Francisco, CA) 2036-04-30 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Johnson and Johnson
UBS
Mallinckrodt
McKesson
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.